Results 11 to 20 of about 1,005,051 (309)

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

open access: yesNew England Journal of Medicine, 2022
BACKGROUND Increases in lipid levels and cancers with tofacitinib prompted a trial of major adverse cardiovascular events (MACE) and cancers in patients with rheumatoid arthritis receiving tofacitinib as compared with a tumor necrosis factor (TNF ...
Ted R Mikuls   +2 more
exaly   +2 more sources

Assessing flares in patients with psoriatic arthritis using questionnaires [PDF]

open access: yesRMD Open
Objectives The psoriatic arthritis (PsA) FLARE Questionnaire was developed to study flares in PsA. We aimed to validate the FLARE Questionnaire and compare it with the Psoriatic Arthritis Impact of Disease 12-item Questionnaire (PsAID-12) to determine ...
Vinod Chandran   +3 more
doaj   +2 more sources

Association of tramadol with all-cause mortality, cardiovascular diseases, venous thromboembolism, and hip fractures among patients with osteoarthritis: a population-based study

open access: yesArthritis Research & Therapy, 2022
Background The use of tramadol among osteoarthritis (OA) patients has been increasing rapidly around the world, but population-based studies on its safety profile among OA patients are scarce.
Lingyi Li   +7 more
doaj   +1 more source

Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

open access: yesThe Lancet Rheumatology, 2023
Summary Background Rheumatoid arthritis is a chronic autoimmune inflammatory disease associated with disability and premature death. Up-to-date estimates of the burden of rheumatoid arthritis are required for health-care planning, resource allocation ...
R. Black   +262 more
semanticscholar   +1 more source

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

open access: yesArthritis & Rheumatology, 2021
To develop updated guidelines for the pharmacologic management of rheumatoid arthritis.
L. Fraenkel   +36 more
semanticscholar   +1 more source

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

open access: yesNew England Journal of Medicine, 2004
Jonathan Edwards   +2 more
exaly   +2 more sources

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee

open access: yesArthritis care & research, 2020
To develop an evidence‐based guideline for the comprehensive management of osteoarthritis (OA) as a collaboration between the American College of Rheumatology (ACR) and the Arthritis Foundation, updating the 2012 ACR recommendations for the management of
S. Kolasinski   +31 more
semanticscholar   +1 more source

Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes

open access: yesNature, 2023
Rheumatoid arthritis is a prototypical autoimmune disease that causes joint inflammation and destruction^ 1 . There is currently no cure for rheumatoid arthritis, and the effectiveness of treatments varies across patients, suggesting an undefined ...
Fan Zhang   +51 more
semanticscholar   +1 more source

Bibliometric and visualization analysis of stem cell therapy for meniscal regeneration from 2012 to 2022

open access: yesFrontiers in Bioengineering and Biotechnology, 2023
Background: Meniscus injuries, a common joint disease caused by long-term wear, trauma and inflammation, usually cause chronic dysfunction and pain in the joint.
Zhen Yang   +12 more
doaj   +1 more source

The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999–2018

open access: yesArthritis Research & Therapy, 2023
Purpose We aimed to explore the relationship between the systemic immune-inflammation index (SII) and rheumatoid arthritis (RA) using NHANES from 1999 to 2018. Methods We collected data from the NHANES database from 1999 to 2018.
Bo Liu   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy